U.S. RESEARCH ROUNDUP-Amazon, Chevron, Mastercard

Reuters11-04

Nov 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amazon, Chevron, and Mastercard, on Monday.

HIGHLIGHTS

* Amazon : Raymond James raises target price to $230 from $205

* Chevron Corp : Raymond James raises target price to $175 from $170

* Mastercard : Macquarie raises target price to $565 from $505

* Vertex Inc : Jefferies raises to buy from hold

* Waters Corp : TD Cowen raises target price to $410 from $363

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

* Amazon : Raymond James raises target price to $230 from $205

* Arcbest Corp : JP Morgan cuts target price to $117 from $130

* Ares Management Corp : CFRA raises target price by $20 to $190

* Avis Budget Group Inc : JP Morgan cuts target price to $150 from $175

* Blue Owl Capital Inc : JP Morgan cuts target price to $23 from $24

* Brightspring Health Services Inc : Mizuho raises target price to $20 from $17

* Brinker International Inc : Piper Sandler raises target price to $97 from $62

* Brinker International Inc : Stifel raises target price to $120 from $110

* BXP Inc : Jefferies raises target price to $93 from $91

* Cardinal Health Inc : Baird raises target price to $145 from $140

* Cavco Industries Inc : Wedbush raises target price to $480 from $455

* Chevron Corp : Raymond James raises target price to $175 from $170

* Chevron Corp : Truist Securities raises target price to $155 from $150

* Conocophillips : Gerdes Energy Research raises target price by $1 to $148

* Customers Bancorp Inc : Wedbush cuts target price to $50 from $53

* DR Horton Inc : JP Morgan raises target price to $188 from $180

* Gilead : Jefferies raises target price to $105 from $95

* Intra-Cellular Therapies Inc : JP Morgan raises target price to $89 from $81

* Kindercare Learning Companies Inc : JP Morgan initiates with overweight rating

* Kindercare Learning Companies Inc : JP Morgan initiates with price target $31

* Madison Square Garden Sports Corp : JP Morgan raises target to $240 from $235

* Mastercard : Macquarie raises target price to $565 from $505

* Moderna : JP Morgan cuts target price to $59 from $70

* Monster Beverage Corp : JP Morgan cuts target price to $49 from $50

* Nektar Therapeutics : Piper Sandler initiates coverage with overweight rating

* Nektar Therapeutics : Piper Sandler initiates coverage with target price $7

* Pediatrix Medical Group Inc : Mizuho raises target price to $15 from $13

* Reinsurance Group of America Inc : Piper Sandler raises target to $252 from $242

* Site Centers Corp : Piper Sandler cuts target price to $20 from $23

* Sprouts Farmers market Inc : JP Morgan raises target price to $131 from $96

* T Rowe price Group Inc : JP Morgan cuts target price to $115 from $116

* Teleflex Inc : Truist Securities cuts target price to $227 from $255

* Uscb Financial Holdings Inc : Raymond James raises to strong buy from outperform

* Uscb Financial Holdings Inc : Raymond James raises target price to $19 from $18

* Veeco Instruments Inc : Oppenheimer cuts target price to $45 from $55

* Vertex Inc : Jefferies raises target price to $50 from $35

* Vertex Inc : Jefferies raises to buy from hold

* Viking Therapeutics Inc : Oppenheimer raises target price to $164 from $138

* Waters Corp : JP Morgan raises target price to $380 from $340

* Waters Corp : TD Cowen raises target price to $410 from $363

* Wingstop Inc : Piper Sandler cuts target price to $300 from $375

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment